【時報記者林資傑台北報導】美系外資出具最新報告，指稱晶圓代工龍頭台積電(2330)決定遞延部分3奈米產能資本支出，預估明年資本支出降至300～320億美元，折舊成本降低使2023～2024年毛利率更可能維持逾53％水準，有望帶動現金報酬率增加，維持「加碼」評等、目標價720元不變。
台積電股價10月底下探370元的27月低點後止跌，近日緩步震盪回升，今（9）日開高後在買盤敲進下帶量走高，一度勁揚4.01％至415元，市值回升至10.76兆元，截至午盤維持逾3.5％漲幅。三大法人本周轉站多方，迄今合計買超達1萬9345張。
DUBLIN, IRELAND / ACCESSWIRE / November 7, 2022 / - Alkermes plc (Nasdaq:ALKS) announced the 2022 recipients of the Alkermes Inspiration Grants® program. Grants were awarded to nine nonprofit organizations working to address the needs of people living with alcohol dependence, opioid dependence, schizophrenia, bipolar I disorder and cancer. The selected programs also have a focus on addressing unmet needs in historically under-resourced or underrepresented communities with longstanding and widespread health disparities.
"This year's Alkermes Inspiration Grants recipients inspire us with their innovative approaches to providing critical support for people living with addiction, serious mental illness or cancer, as well as their caregivers and family members. These organizations have the potential to positively impact people across the U.S. and offer an opportunity to engage diverse communities in new ways," said Richard Pops, Chief Executive Officer of Alkermes.
過去幾年，新冠疫情（COVID-19）的陰霾壟罩全球，不只造成社會互動模式鉅變，也促成強勁的數位轉型浪潮，推進我國公私部門的數位轉型進程，在遠距醫療方面更是有所進展。
遠距診療的開放讓偏鄉地區的民眾有機會獲得更多樣的醫療服務；搭配全程都會有醫師及專人陪伴的「會診模式」，民眾就只要到衛生所掛號、申請遠距診療，就能在鄰近的衛生所完成看診過程，結束後也可以在原地批價、領藥，免去舟車勞頓與掛號等待的時間。
日月光投控（3711）旗下日月光半導體今（4）日宣布，VIPack平台系列中首創FOCoS扇出型基板晶片封裝技術，主要分為Chip First (FOCoS-CF) 以及Chip Last (FOCoS-CL) 兩種工藝流程解決方案，在基板上增添多晶片以及小晶片(Chiplet)整合，可更有效提升高效能運算性能，鎖定HPC、人工智能、5G和汽車等重要應用。
